Investigating the Role of Ginger Tea ORAC Value in Hypertension Management
1 other identifier
interventional
50
1 country
2
Brief Summary
The purpose of this study is to evaluate the antihypertensive effects of ginger tea. By examining its impact on blood pressure levels, this research aims to determine whether ginger tea can be an effective, natural adjunct to conventional hypertension treatments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Mar 2024
Shorter than P25 for not_applicable hypertension
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 17, 2024
CompletedFirst Posted
Study publicly available on registry
January 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedJanuary 8, 2025
January 1, 2025
7 months
December 17, 2024
January 6, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Systolic Blood Pressure (SBP)
Measure changes in SBP before and after the intervention with ginger tea over a defined period.
12 Months
Total ORAC Value
Measure the total Oxygen Radical Absorbance Capacity (ORAC) value of ginger tea consumed by participants to evaluate its antioxidant capacity and potential correlation with blood pressure changes.
12 Months
Diastolic Blood Pressure (DBP)
Measure changes in DBP before and after the intervention with ginger tea over a defined period.
12 months
Study Arms (2)
Ginger Tea
EXPERIMENTALSelf Administered Tea
ACTIVE COMPARATORInterventions
determine the optimal dosage of ginger tea that produces significant blood pressure reduction without adverse effects.
To identify consumption and its correlation with blood pressure outcomes using a self- reported diary and periodic clinical assessments.
Eligibility Criteria
You may qualify if:
- Adults aged 30-65 years
- Diagnosed with stage 1 or stage 2 hypertension
- Not currently taking antihypertensive medication
- Willing to provide informed consent and adhere to study protocols.
You may not qualify if:
- Pregnant or breastfeeding women
- Participants on antioxidant supplements or other herbal teas.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Azra Naheed Medical College, Superior University
Lahore, Punjab Province, Pakistan
Chaudary Muhammad Akram Teaching Hospital, Azra Naheed Medical College, Superior University
Lahore, Punjab Province, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 17, 2024
First Posted
January 8, 2025
Study Start
March 1, 2024
Primary Completion
October 1, 2024
Study Completion
March 1, 2025
Last Updated
January 8, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share